Scientists at National Cancer Institute discuss research in algorithms

A new study, "A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients," is now available. According to recent research published in the journal Annals of Epidemiology, "We evaluated (i) how combining comorbid conditions identified from Medicare inpatient or physician claims into a single comorbidity index compared with three other comorbidity indices and (ii) the need for comorbid condition weights that are specific to different cancer sites. This observational study used the SEER-Medicare linked database, from which four cohorts of cancer patients were derived: breast (n=26,377), prostate (n=53,503), colorectal...

Want to see the full article?

• Purchase this article for only $3.00